When people in biotech hear the word marketing, they often think of ads, social media, or a nice-looking website.
That is part of it, but usually not the part that matters first.
Most biotech startups do not struggle because they are under-advertised. They struggle because the science is still too hard to place, the value is still too hard to explain, or the story is not yet clear enough for investors, partners, and customers to act on.
That is where marketing starts.
In biotech, marketing is not just promotion. It is part of how a company becomes understandable, credible, and commercially relevant.
Biotech Marketing starts before promotion
A common mistake is to think marketing begins once there is something to post, design, or advertise.
In reality, it starts earlier.
Before ads, before campaigns, before the LinkedIn post that gets four likes and one from your colleague, there is a more important question:
Do the right people understand what your company is building, why it matters, and why now?
If the answer is no, then promotion usually just spreads confusion faster.
For a biotech startup, marketing often starts with:
- understanding who the key audiences are
- clarifying what problem matters most
- shaping the positioning
- translating the science into language people can follow
- making sure the story holds up across decks, websites, and conversations
That may not sound like “marketing” in the billboard sense, but it is exactly the work that makes later growth possible.
In biotech, marketing is partly translation
Biotech companies are often built around complex technologies, long timelines, and specialised knowledge.
Inside the company, that can feel obvious. Outside the company, not always.
A founder may know the science inside out. A scientist may understand the mechanism perfectly. A business developer may know which application matters most commercially. But if those pieces do not come together in a way that external audiences can understand, communication starts to drag.
That is where marketing becomes translation.
Not translation in the sense of oversimplifying the science or turning everything into startup theatre. Just translation in the sense of helping different audiences understand what matters to them.
Because investors, partners, and customers are not all listening for the same thing.
Investors want to understand the opportunity, differentiation, and why this is worth backing now.
Partners want to understand the fit.
Customers want to understand the relevance.
Technical stakeholders want to know the science holds up.
Good biotech marketing helps a company communicate across those audiences without sounding like it is telling four completely different stories.
What biotech marketing actually includes
This is where a lot of confusion starts. Marketing in biotech is often reduced to a few visible things: website design, social posts, maybe some ads if the budget allows for it.
But the actual scope is broader.
Depending on the stage of the company, biotech marketing can include:
Positioning
How should the company and its innovation be understood in the market? What makes it different, and what should people remember?
Messaging
How do you explain the science in a way that is still accurate, but easier to grasp for investors, partners, and customers?
Investor communication
How does the company present the opportunity in a way that makes sense? This often shows up in pitch decks, fundraising materials, and the overall narrative around the business.
Website and materials
A website is often one of the first places people go when they hear about a company. The same goes for pitch decks, brochures, one-pagers, and presentations. These materials need to do more than look polished. They need to help people understand the company quickly.
Digital visibility
This includes channels like LinkedIn, search, content, email, or paid campaigns. The goal is not “being active online” for the sake of it. The goal is to create visibility that supports real conversations and real growth.
Growth support
As a startup starts moving, marketing can also support launches, commercial traction, lead generation, and partnerships.
So no, marketing is not just ads and nice pictures. Those can be useful. But they are not the foundation.
Why biotech startups often think about marketing too late
A lot of startups treat marketing like something for later.
First the science. Then the product. Then the next funding milestone. Then maybe, somewhere down the line, marketing.
That makes sense on paper. In practice, it often creates friction.
Because by the time people start saying “we need marketing,” the actual problem is usually bigger than visibility. It is often:
- the positioning is still fuzzy
- the website does not explain the value clearly
- the investor deck is too technical
- the messaging changes depending on who is talking
- the company knows what it does, but not yet how to make others understand it quickly
In other words, the issue is not just lack of promotion. It is lack of clarity.
And clarity is much easier to build earlier than to patch later when a launch, raise, or campaign is already around the corner.
A simple way to tell if marketing is missing
A biotech startup does not need to run a huge content engine or launch ads on five platforms to know whether marketing needs work.
A few simple signs are usually enough.
Marketing may be missing if:
- people keep asking what the company actually does
- the science gets explained, but the value stays vague
- the deck is full of information, but the opportunity does not land
- the website is accurate, but not memorable
- different team members describe the company in different ways
- there is activity, but not much traction
That does not mean the company is failing. It usually just means the communication has not caught up with the quality of the work yet.
And to be fair, that is common in biotech. Many teams are wearing multiple hats. Founders switch between science, fundraising, and operations. Scientists are pulled into business conversations. Business developers are expected to explain technical value across different audiences.
That is exactly why clearer marketing matters. It helps the whole company communicate better, not just the marketing function.
So what should marketing do for a biotech startup?
At its best, marketing should help a biotech startup become easier to understand, easier to trust, and easier to act on.
That might mean helping investors see the opportunity faster.
It might mean making the website support the story instead of slowing it down.
It might mean sharpening the positioning so the company is easier to place in the market.
Or it might mean building digital visibility around a message that is finally clear enough to travel.
Whatever the form, the purpose is the same: to help the company communicate in a way that supports real progress.
Because strong science deserves more than vague communication and a few decent visuals.
It deserves a story, structure, and market presence that do the work justice.
Final thought
If marketing feels vague inside a biotech startup, that usually means it has been defined too narrowly.
Marketing is not just what happens at the end when it is time to promote. It is part of how a company makes its science understandable, its value visible, and its growth more deliberate.
And that starts much earlier than most teams think.
Need help turning complex science into clearer positioning, stronger communication, and marketing that supports growth? Explore Biotech Marketing Strategy or Positioning & Messaging.